Prabha Raghavan

The Indian Electricity Grid Code lays down rules for participants in the power ecosystem to plan, develop, maintain and operate power system, states the draft.

The draft National Policy for Rare Diseases proposes a digital platform for bringing together notified hospitals with such patients and prospective donors.

Dr Reddy, says that any policy developed by the government should not be knee-jerk, and should focus on ensuring affordability, availability and quality.

The National Pharmaceutical Pricing Authority (NPPA), along with the Department of Pharmaceuticals (DoP), has been finalising a proposal to limit the trade margins of non-scheduled medicines and medical devices, which are not under price control.

In the words of the Commerce Ministry, Indian industry and services will be competitive and benefit from access to “large developed markets”.

The regulator this month labelled specific batches of Coxerin as well as Rabium-DSR to be “not of standard quality”.

Discom losses, which had progressively reduced in the first couple of years since the scheme’s rollout in November 2015, have rebounded in FY ’19 to nearly double the losses recorded the previous year.

Most of the prominent India Inc leaders excused themselves from talking on the ongoing protests. A few who responded to queries said that while people have a right to protest, these mass demonstrations contribute to building a negative image and could hit investment sentiment.

Cashless services for the Ex-Servicemen Contributory Health Scheme (ECHS) may also be suspended, he said, adding that the association will wait for “about a month” for dues to be cleared.

Over 18 lakh beneficiaries across the country used services under ECHS in 2018-19, shows government data.

According to the regulator, the firm has submitted a patent document for a ‘bioabsorbable’ stent, but its licence from the Drug Controller General of India (DCGI) was for a ‘bioresorbable’ stent.

This is the first time the National Pharmaceutical Pricing Authority (NPPA) — which is known to slash prices of essential and life-saving medicines — is increasing prices in public interest.

Vildagliptin, which belongs to DPP-4 class of drugs, was launched in India in 2008 for treating type-2 diabetes.

The bodies have written to Minister of Chemicals and Fertilizers DV Sadananda Gowda, calling for a statutory code to prevent corruption and unethical marketing practices in these industries.

The third figure in the Ranbaxy brothers’ corporate battle is Gurinder Singh Dhillon, the head of Radha Soami Satsang Beas — among the largest such communes in the world, with 20 mn followers in 90 countries, yet fiercely secretive. The Indian Express on the man and his sect

At the same time, BCPL and HAL have disputed the claim that the samples were sub-standard, with BCPL also planning to challenge CDSCO’s findings.

At the same time, the companies that market these products in India have said that the samples tested were counterfeited versions of their popular brands.

During a meeting held with various stakeholders on the issue, officials of the National Pharmaceutical Pricing Authority (NPPA) and the Department of Pharmaceuticals sought inputs on how much margins should be allowed for these products across the supply chain, said persons directly aware of the development.

Of the country’s total installed generation capacity of 3,63,370 MW, the peak demand met was a little less than half at just around 1,88,072 MW on November 7, according to official data available with grid managers and analysed by The Indian Express.